Hong Kong Pharmaceuticals & Biotech Nano Cap Stocks

Austar Lifesciences

Market Cap: HK$361.4m

An investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally.

Uni-Bio Science Group

Market Cap: HK$358.3m

An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in Hong Kong, and People’s Republic of China.

Wai Yuen Tong Medicine Holdings

Market Cap: HK$323.2m

An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.

Shenzhen Neptunus Interlong Bio-technique

Market Cap: HK$176.2m

Engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China.

Kontafarma China Holdings

Market Cap: HK$167.7m

An investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediates in Mainland China, Singapore, Taiwan, and internationally.